HSPB1 and breast carcinoma: As an oncogene, HSPB1 promotes the activity of breast cancer cells by regulating the EMT process, thus establishing HSPB1 as a promising biomarker for the diagnosis and treatment of breast cancer; however, the potential mechanism by which HSPB1 affects cell proliferation and EMT requires further investigation.